Consequently, for reasons beyond the control of the applicant, the approval of IPBC for use in biocidal products of product-type 8 is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the application. Taking into account the time needed for the evaluation by the evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinion, and for the Commission to decide whether to renew the approval of IPBC for use in biocidal products of product-type 8, the expiry date should be postponed to 31 July 2025.
Recital 7, Decision_act (EU) 2022/1485
In forcesince 7 Sep 2022